Felix Lourdes has filed 13 insider transactions across 3 companies since December 2022.
Most recent transaction: a grant/award of 25000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. ($LIXT) on December 24, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 24, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Felix Lourdes | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 6,171,195 | 9999.99% | 0.41% |
| Aug. 11, 2025 | La Rosa Holdings Corp. | $LRHC | Felix Lourdes | Director | A | Common Stock | 600 | $0.00 | 600.0000 | 5,135,893 | 9999.99% | 0.01% |
| July 2, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 500000 | $0.00 | 814,795.0000 | 0 | 158.83% | 0.00% |
| Sept. 30, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 15625 | $0.00 | 830,420.0000 | 0 | 1.92% | 0.00% |
| Dec. 31, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 13158 | $0.00 | 843,578.0000 | 0 | 1.58% | 0.00% |
| April 24, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 224196 | $0.00 | 314,795.0000 | 0 | 247.46% | 0.00% |
| June 28, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 10204 | $0.00 | 90,599.0000 | 0 | 12.69% | 0.00% |
| March 28, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 5566 | $0.00 | 80,395.0000 | 0 | 7.44% | 0.00% |
| Jan. 2, 2024 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 6173 | $0.00 | 74,829.0000 | 0 | 8.99% | 0.00% |
| Sept. 29, 2023 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 2858 | $0.00 | 68,656.0000 | 0 | 4.34% | 0.00% |
| June 30, 2023 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 2891 | $0.00 | 65,798.0000 | 0 | 4.60% | 0.00% |
| March 31, 2023 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 2824 | $0.00 | 62,907.0000 | 0 | 4.70% | 0.00% |
| Dec. 30, 2022 | BioCorRx Inc. | $BICX | Felix Lourdes | CEO and CFO | A | Common Stock, par value $0.001 | 5319 | $0.00 | 60,083.0000 | 0 | 9.71% | 0.00% |